Premium
S4‐01‐04: Phase IIa clinical trial on Alzheimer's disease with NP12, a GSK3 inhibitor
Author(s) -
Teodoro del Ser
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.455
Subject(s) - placebo , medicine , tolerability , adverse effect , clinical trial , gsk 3 , mood , asymptomatic , psychiatry , kinase , pathology , alternative medicine , biology , microbiology and biotechnology